These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 16919599)
1. Suppression of hypoxia inducible factor-1alpha (HIF-1alpha) by YC-1 is dependent on murine double minute 2 (Mdm2). Lau CK; Yang ZF; Lam CT; Tam KH; Poon RT; Fan ST Biochem Biophys Res Commun; 2006 Oct; 348(4):1443-8. PubMed ID: 16919599 [TBL] [Abstract][Full Text] [Related]
2. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells. Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818 [TBL] [Abstract][Full Text] [Related]
3. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells. Zhao Q; Du J; Gu H; Teng X; Zhang Q; Qin H; Liu N Pancreas; 2007 Mar; 34(2):242-7. PubMed ID: 17312464 [TBL] [Abstract][Full Text] [Related]
4. YC-1 induces S cell cycle arrest and apoptosis by activating checkpoint kinases. Yeo EJ; Ryu JH; Chun YS; Cho YS; Jang IJ; Cho H; Kim J; Kim MS; Park JW Cancer Res; 2006 Jun; 66(12):6345-52. PubMed ID: 16778212 [TBL] [Abstract][Full Text] [Related]
5. [Inhibitory effect of YC-1 on induction of VEGF and GPI genes in hypoxic human pancreatic cancer cells]. Du J; Zhao Q; Gu H; Teng XL; Qin H; Liu NZ Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):486-9. PubMed ID: 17147109 [TBL] [Abstract][Full Text] [Related]
6. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia. Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816 [TBL] [Abstract][Full Text] [Related]
7. Effects of YC-1 targeting hypoxia-inducible factor 1 alpha in oesophageal squamous carcinoma cell line Eca109 cells. Feng Y; Zhu H; Ling T; Hao B; Zhang G; Shi R Cell Biol Int; 2011 May; 35(5):491-7. PubMed ID: 20977428 [TBL] [Abstract][Full Text] [Related]
8. A domain responsible for HIF-1alpha degradation by YC-1, a novel anticancer agent. Kim HL; Yeo EJ; Chun YS; Park JW Int J Oncol; 2006 Jul; 29(1):255-60. PubMed ID: 16773207 [TBL] [Abstract][Full Text] [Related]
9. YC-1 exerts inhibitory effects on MDA-MB-468 breast cancer cells by targeting EGFR in vitro and in vivo under normoxic condition. Cheng Y; Li W; Liu Y; Cheng HC; Ma J; Qiu L Chin J Cancer; 2012 May; 31(5):248-56. PubMed ID: 22507221 [TBL] [Abstract][Full Text] [Related]
10. YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. Yeo EJ; Chun YS; Cho YS; Kim J; Lee JC; Kim MS; Park JW J Natl Cancer Inst; 2003 Apr; 95(7):516-25. PubMed ID: 12671019 [TBL] [Abstract][Full Text] [Related]
11. YC-1 [3-(5'-Hydroxymethyl-2'-furyl)-1-benzyl Indazole] exhibits a novel antiproliferative effect and arrests the cell cycle in G0-G1 in human hepatocellular carcinoma cells. Wang SW; Pan SL; Guh JH; Chen HL; Huang DM; Chang YL; Kuo SC; Lee FY; Teng CM J Pharmacol Exp Ther; 2005 Mar; 312(3):917-25. PubMed ID: 15525795 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia-induced overexpression of DEC1 is regulated by HIF-1α in hepatocellular carcinoma. Ma W; Shi X; Lu S; Wu L; Wang Y Oncol Rep; 2013 Dec; 30(6):2957-62. PubMed ID: 24100543 [TBL] [Abstract][Full Text] [Related]
13. [Effects of hypoxia-inducible factor inhibitor on expression of HIF-1alpha and VEGF and induction of apoptosis in leukemic cell lines]. Wang F; Chen BA; Cheng J; Xu WL; Wang XM; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Bao W; Song HH; Gao F; Zhang W; Xia GH; Pei XP; Wu WW; Yin L; Shan XY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):74-8. PubMed ID: 20137122 [TBL] [Abstract][Full Text] [Related]
14. The effect of 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1) on cell viability under hypoxia. Tsui L; Fong TH; Wang IJ Mol Vis; 2013; 19():2260-73. PubMed ID: 24265542 [TBL] [Abstract][Full Text] [Related]
15. The effect of hypoxia-inducible factor 1-alpha on hypoxia-induced apoptosis in primary neonatal rat ventricular myocytes. Zhou YF; Zheng XW; Zhang GH; Zong ZH; Qi GX Cardiovasc J Afr; 2010; 21(1):37-41. PubMed ID: 20224844 [TBL] [Abstract][Full Text] [Related]
16. YC-1 sensitizes the antitumor effects of boron neutron capture therapy in hypoxic tumor cells. Harada T; Hirose K; Wada Y; Sato M; Ichise K; Aoki M; Kato T; Takeda K; Takai Y J Radiat Res; 2020 Jul; 61(4):524-534. PubMed ID: 32367141 [TBL] [Abstract][Full Text] [Related]
17. Sorafenib inhibits hypoxia-inducible factor-1α synthesis: implications for antiangiogenic activity in hepatocellular carcinoma. Liu LP; Ho RL; Chen GG; Lai PB Clin Cancer Res; 2012 Oct; 18(20):5662-71. PubMed ID: 22929805 [TBL] [Abstract][Full Text] [Related]
18. Sorafenib blocks the HIF-1α/VEGFA pathway, inhibits tumor invasion, and induces apoptosis in hepatoma cells. Xu M; Zheng YL; Xie XY; Liang JY; Pan FS; Zheng SG; Lü MD DNA Cell Biol; 2014 May; 33(5):275-81. PubMed ID: 24611881 [TBL] [Abstract][Full Text] [Related]
19. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis. DeNiro M; Alsmadi O; Al-Mohanna F Exp Eye Res; 2009 Nov; 89(5):700-17. PubMed ID: 19580810 [TBL] [Abstract][Full Text] [Related]
20. Advances in antitumor research of HIF-1α inhibitor YC-1 and its derivatives. Ouyang C; Zhang J; Lei X; Xie Z; Liu X; Li Y; Huang S; Wang Z; Tang G Bioorg Chem; 2023 Apr; 133():106400. PubMed ID: 36739684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]